Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Reward-based Technology to Improve Opioid Use Disorder Treatment Initiation After an ED Visit - Phase 2

NCT05180669 is registered in ClinicalTrials.gov with Q2i, LLC as lead sponsor.

NCT NCT05180669
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05180669 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Reward-based Technology to Improve Opioid Use Disorder Treatment Initiation After an ED Visit - Phase 2
Lead sponsor
Q2i, LLC
Phase
Not applicable
Overall status
Terminated
Start date
November 18, 2022
Completion date
May 31, 2025
Enrollment
41 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

opioid use disorder